Joseph Dusseldorp

Dr. Joseph Dusseldorp is a Clinical Senior Lecturer at the University of Sydney's Sydney Medical School, specifically within the Central Clinical School under the Faculty of Medicine and Health. He is a Specialist Plastic and Reconstructive Surgeon with a focus on integrating emerging technologies into medical practice, particularly in addressing neuromotor disorders and peripheral nervous system conditions. His academic and clinical roles are complemented by extensive research in implanted electronics, tissue engineering, and artificial intelligence.

• Education: B.Com, MBBS (Hons) from the University of Sydney, M.S. in Plastic Surgery, and Fellow of the Royal Australasian College of Surgeons (FRACS).
• Affiliations: Royal Australasian College of Surgeons (RACS), Australian Society of Plastic Surgeons (ASPS), and Sydney Neurobionics Collaboration.

His research interests span implanted electronics for neuromotor disorders, 3D bioprinting for tissue engineering, and AI-driven surgical outcomes. Notable projects include the Liberty Trial (Closed-Loop Spinal Cord Stimulation for spasticity) and co-founding the Sydney Neurobionics Collaboration to explore neural interfaces. He has secured multiple grants, including the MRFF Stage One Grant ($747,596) and MDCTP training.

Dr. Dusseldorp’s publications emphasize facial palsy management, nerve surgery, and AI applications in reconstructive surgery. He actively participates in global surgical missions, performing cleft lip/palate and auricular reconstruction in underserved regions like Guatemala, Uganda, and Haiti.

• Awards: Over 20 awards/grants including RHRF Grant ($180k), MDPP Grant, and Herbert John Wilkinson Memorial Prize.
• Grants & Commercialization: Co-PI on Liberty Trial, MDCTP training, and involvement in medical device commercialization.

He leads interdisciplinary collaborations with biomedical engineers and hospitals, advancing translational research in neurobionics and regenerative medicine. His TEDx talk, 'Personalizing Medicine,' highlights technology’s role in overcoming medical challenges, reflecting his commitment to bridging innovation and clinical care.